Thought Leadership Conference Returns In-Person: Customers, Partners and Industry Experts Collaborate on Risk Innovation, Third-Party…
– Registrational studies planned to start in 4Q 2022 – – Two-year data from Phase…
Key leadership appointments focused on enhancing connections and collaboration to drive Innovation across the next-generation delivery…
Follows CDC & World Health Organization’s (WHO) announcement that US now meets criteria for country with circulating…
BRIDGEWATER, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or…
–The Company Highlights its Clinical Strategy for its Adenosine and iNKT Platforms– –Clinical Development Goals…
NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’…
– Transaction values Apollomics at pre-money equity value of $899 million – Apollomics is a…
AGOURA HILLS, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF AUGUST 2022 VANCOUVER, BC, CANADA , Sept….
EDISON, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
All Merger-related proposals approved at the Annual Meeting of Stockholders BASKING RIDGE, N.J., Sept. 14,…
– Dose escalation based on positive recommendation from independent data safety monitoring board after safety…
TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
SAN DIEGO, Sept. 14, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
CARLSBAD, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (Nasdaq: PRDS), a clinical-stage…
LUNA Phase 2 Study in Wet AMD – Study Design Objective: The LUNA trial is…
European Commission expected to issue its decision on orphan designation in approximately 30 days BASKING…
Redefining Expectations for PBC Patients September 22, 2022 at 10:30 AM ET NEWARK, Calif., Sept….
PRAGUE, Czech Republic, Sept. 14, 2022 (GLOBE NEWSWIRE) — SOTIO Biotech, a clinical stage immuno-oncology…